All Emma Walmsley articles
-
BusinessGSK stops over 30 research programmes to prioritise innovation
New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects
New boss Emma Walmsley outlines sweeping changes in order to focus on high-return drug projects